Making Cost Savings Count Upgrading to MEDRAD® Stellant FLEX CT Injection System Drives Cost Efficiencies and Standardization for Windsong Radiology Group
Key Takeaways Windsong Radiology Group is a New York-based
radiology practice with five locations. Recently, Windsong
participated in a controlled commercial release (CCR)
of the MEDRAD® Stellant FLEX CT Injection System, the
newest MEDRAD CT Injection System. Their participation
allowed them to examine how the technology could
improve their existing processes while lending their input
to Bayer ahead of the company’s widespread platform
release. Following the CCR, Windsong detailed how the
MEDRAD® Stellant FLEX CT Injection System and Bayer’s CT
non-obsolescence program have been key to helping them
minimize operational costs, standardize care and avoid
downtime.
Partnering with Bayer for their equipment needs allowed
Windsong to achieve a number of primary metrics that are
critical to their cost efficiency goals:
• Staying current with equipment at an affordable rate• Maintaining reproducible and consistent image quality for “apples to apples comparisons”
throughout a patient’s care journey
• Reducing operating costs• Benefitting from continued product reliability and maximizing up-time
Avoiding Obsolescence and Minimizing DowntimeHealthcare is evolving, and Windsong, like other radiology
centers across the country, is faced with the balancing
act of providing high-quality, value-based care while also
meeting their budgetary needs.
Participating in the MEDRAD®
Stellant FLEX CT Injection System
CCR gave Windsong the ability to
experience how the new CT injection
system and TechCARE program
are optimized to help imaging
providers save on operational costs
and limit downtime. When coupled
with Bayer’s CT non-obsolescence
program – which delivers all the
benefits of Bayer Equipment Service
-- MEDRAD® Stellant FLEX CT
Injection System provided Windsong with the boost they
needed to maximize their profits in the face of declining
reimbursements. It also helped them affordably enact a
future-proofed plan for staying up to date with the most
current injection system technology.
“One reason why we jumped on
Bayer’s CT non-obsolescence
program is because, for a very small
sum, we were able to replace all of
our injectors. We spent a fraction
of what it would normally cost,”
said An. “Bayer realizes where
medical imaging is headed,” added
An, reinforcing that Windsong’s
partnership with Bayer allowed the practice to avoid
obsolescence as they continue to grow and consider
opening additional office locations.
“Our biggest hurdle
right now is declining
reimbursements,” said
Bryan An, Windsong’s
supervisor of MRI and
CT. “The cost of doing
business has not
gone down, but our
reimbursements have.”
Bryan An, Supervisor of CT and MRI, Windsong Radiology Group
Capitalizing on ReliabilityWindsong chose to participate in the CCR for MEDRAD®
Stellant FLEX CT Injection System due to their long-
standing relationship with Bayer and the history of
reliability with their MEDRAD injection
systems. Sharing his personal
experience, An credited the reliability
of MEDRAD as a major reason that
Windsong has been able to efficiently
manage operational costs.
“I’ve been using MEDRAD® injectors
since 1998, and I can’t remember a time
where we had any extended downtime
because of an injector.” He added
that when the practice was previously
provided with a competitor’s injector at
no cost, Windsong chose to return it due
to inconsistent performance.
Windsong’s CCR experience was a positive one, said An.
“If asked by another provider, I would recommend the
MEDRAD® Stellant FLEX because it’s a good product with
high reliability, combined with great services provided by
Bayer.”
Overcoming Financial HurdlesCost has always been a major factor in healthcare, but
the current landscape is making it more difficult than
ever for providers to maintain cost efficiency. It’s a
challenge that Windsong knows well and has worked
hard to effectively manage.
Meeting Needs in the Current ClimateMEDRAD® Stellant FLEX CT Injection System is designed
to set providers up for success — both in terms of the
radiology services they provide and their operational
metrics. At Windsong, unique features
like smaller syringes and improved
loading have improved the practice’s
workflow, as well as their ability
to keep costs down over time. “The
enhanced design of the MEDRAD®
Stellant FLEX CT Injection System made
the decision to upgrade easy,” said An,
noting that the injection system allows
them to consistently inject contrast
and the importance of reproducibility.
Windsong is far from alone in their
need to choose equipment and services
that align with their financial goals
and challenges. An said that after
working with the MEDRAD® Stellant FLEX CT Injection
System firsthand he would recommend that other
radiology practices make the switch.
“You should treat your patients like your own family,
and I would want my family to have a study done with
a MEDRAD® injection system versus any other injector,”
said An. He noted that as Windsong continues to expand
their services, they plan to rely on Bayer’s comprehensive
portfolio to ensure they provide the best possible care at
the most reasonable cost.
2
“One reason why we
jumped on Bayer’s CT non-
obsolescence program is
because, for a very small
sum, we were able to
replace all of our injectors.
We spent a fraction of what
it would normally cost,”
said An. “Bayer realizes
where medical imaging is
headed,”
MEDRAD® Stellant FLEX CT Injection System Windsong Radiology Group
3
“We’ve experienced increased procedure
volume in several modalities, yet
our reimbursement has gone down
significantly,” said An. “It’s an issue that’s
all too familiar for radiology providers, and
one that I believe Bayer is actively working
on through their innovative portfolio
offerings that can help customers control
costs.”
PP-M
-STE
-F-U
S-01
00-1
Ja
nuar
y 20
20
Bayer HealthCare LLC100 Bayer BoulevardP.O. Box 915Whippany, NJ 07981U.S.A.Phone: +1-412-767-2400 +1-800-633-7231Fax: +1-412-767-4120
More information onradiologysolutions.bayer.com
Bayer reserves the right to modify the specifications and features described herein or to discontinue any product or service identified in this publication at any time without prior notice or obligation. Please contact your authorized Bayer representative for the most current information.
Patient Information listed on the Graphical User Interfaces are fictious examples only and do not contain any actual patient data.
Bayer, the Bayer Cross, MEDRAD, MEDRAD Stellant, Stellant, MEDRAD Stellant FLEX, and Stellant FLEX are trademarks owned by and/or registered to Bayer in the U.S. and/or other countries. Other trademarks and company names mentioned herein are properties of their respective owners and are used herein solely for informational purposes. No relationship or endorsement should be inferred or implied.
© 2019 Bayer. This material may not be reproduced, displayed, modified or distributed without the express prior written consent of Bayer.
Manufacturer Bayer Medical Care Inc.1 Bayer DriveIndianola, PA 15051-0780U.S.A.Phone: +1-412-767-2400 +1-800-633-7231Fax: +1-412-767-4120